• DNDi_Logo_No-Tagline_Full Colour
  • Our work
    • Diseases
      • Sleeping sickness
      • Visceral leishmaniasis
      • Cutaneous leishmaniasis
      • Chagas disease
      • Parasitic worms
      • Mycetoma
      • Dengue
      • Paediatric HIV
      • Cryptococcal meningitis
      • Hepatitis C
      • Pandemic preparedness
      • Antimicrobial resistance
    • Research & development
      • R&D portfolio & list of projects
      • Drug discovery
      • Translational research
      • Clinical trials
      • Registration & access
      • Evidence for impact
      • Treatments delivered
    • Advocacy
      • Open and collaborative R&D
      • Transparency of R&D costs
      • Pro-access policies and IP
      • Children’s health
      • Gender equity
      • Climate change
      • AI and new technologies
  • Networks & partners
    • Partnerships
      • Our partners
      • Partnering with us
    • Global networks
      • Chagas Platform
      • Dengue Alliance
      • HAT Platform
      • LEAP Platform
      • redeLEISH Network
    • DNDi worldwide
      • DNDi Switzerland
      • DNDi Eastern Africa
      • DNDi Japan
      • DNDi Latin America
      • DNDi North America
      • DNDi South Asia
      • DNDi South-East Asia
      • DNDi West and Central Africa
  • News & resources
    • News & stories
      • News
      • Stories
      • Statements
      • Viewpoints
      • Social media
      • eNews Newsletter
    • Press
      • Press releases
      • In the media
      • Podcasts, radio & TV
      • Media workshops
    • Resources
      • Scientific articles
      • Our publications
      • Videos
    • Events
  • About us
    • About
      • Who we are
      • Our story
      • How we work
      • Our strategy
      • Our donors
      • Annual reports
      • Our prizes and awards
    • Our people
      • Our leadership
      • Our governance
      • Contact us
    • Work with us
      • Working at DNDi
      • Job opportunities
      • Requests for proposal
  • Donate
  • DNDi_Logo_No-Tagline_Full Colour
  • Our work
    • Diseases
      • Sleeping sickness
      • Visceral leishmaniasis
      • Cutaneous leishmaniasis
      • Chagas disease
      • Parasitic worms
      • Mycetoma
      • Dengue
      • Paediatric HIV
      • Cryptococcal meningitis
      • Hepatitis C
      • Pandemic preparedness
      • Antimicrobial resistance
    • Research & development
      • R&D portfolio & list of projects
      • Drug discovery
      • Translational research
      • Clinical trials
      • Registration & access
      • Evidence for impact
      • Treatments delivered
    • Advocacy
      • Open and collaborative R&D
      • Transparency of R&D costs
      • Pro-access policies and IP
      • Children’s health
      • Gender equity
      • Climate change
      • AI and new technologies
  • Networks & partners
    • Partnerships
      • Our partners
      • Partnering with us
    • Global networks
      • Chagas Platform
      • Dengue Alliance
      • HAT Platform
      • LEAP Platform
      • redeLEISH Network
    • DNDi worldwide
      • DNDi Switzerland
      • DNDi Eastern Africa
      • DNDi Japan
      • DNDi Latin America
      • DNDi North America
      • DNDi South Asia
      • DNDi South-East Asia
      • DNDi West and Central Africa
  • News & resources
    • News & stories
      • News
      • Stories
      • Statements
      • Viewpoints
      • Social media
      • eNews Newsletter
    • Press
      • Press releases
      • In the media
      • Podcasts, radio & TV
      • Media workshops
    • Resources
      • Scientific articles
      • Our publications
      • Videos
    • Events
  • About us
    • About
      • Who we are
      • Our story
      • How we work
      • Our strategy
      • Our donors
      • Annual reports
      • Our prizes and awards
    • Our people
      • Our leadership
      • Our governance
      • Contact us
    • Work with us
      • Working at DNDi
      • Job opportunities
      • Requests for proposal
  • Donate
Home > News

Filaria in Ghana – Slideshow

Home > News

Filaria in Ghana – Slideshow

Dr. Linda Batsa Debrah examines Ama Dadiesa, 61, who has LF, causing swelling and "mossy" skin on her leg. Because of her condition, her husband divorced her and abandoned her and her children.
18 Jun 2014

Filaria is a group of neglected tropical diseases infecting over 150 million people in sub-Saharan Africa, Asia, and Latin America. The two main filarial diseases, onchocerciasis (river blindness) and lymphatic filariasis (elephantiasis), devastate the lives of patients, causing debilitating symptoms and social discrimination. In March 2014, DNDi traveled to rural Ghana to meet and interview patients with filaria and the physician-researchers treating them.

River near Mankattah village, Dunkwa district, southern Ghana, an area endemic for onchocerciasis (river blindness). The black flies that transmit onchocerciasis are believed to breed in the river.
Setting up a medical examination tent in Mankattah village, Dunkwa district, southern Ghana, an area endemic for onchocerciasis (river blindness).
Medical research team from KCCR (Kumasi, Ghana), explaining the day’s activities to patients, Mankattah village. Speaking: Research Assistant Yusif Mubarik; seated: Prof. Achim Hoerauf (left), Dr. Alexander Debrah (right).
Dr. Alexander Debrah points to skin nodule on Kwame Michael Ntumi, 48, who has onchocerciasis. The nodule contains many adult filarial worms, which can live for 15 years.
Dr. Linda Batsa Debrah (left) with Gladys Bediako, 30, a patient with onchocerciasis from Mankattah village. Ms. Bediako suffers intense itching and body pain, often preventing her from working.
“Leopard skin” (discoloration of the skin) due to onchocerciasis is visible on these patients’ legs. This condition can cause social stigmatization and embarrassment for the patient.
View of Asemkow, a coastal village in Ghana, where lymphatic filariasis (LF, or elephantiasis) is endemic. Most of the people in Asemkow village make a living through catching and selling fish.
Dr. Linda Batsa Debrah examines Ama Dadiesa, 61, who has LF, causing swelling and “mossy” skin on her leg. Because of her condition, her husband divorced her and abandoned her and her children.
Adwoa Mamsowaa, 49, from the nearby village of Asemasa, has LF, causing massive swelling of her leg and recurrent attacks of body pain. When these attacks occur, she is not able to work.
Drawing blood to test for LF, in Asemkow village. Doctors use a rapid diagnostic immunochromatographic test (ICT) that can give a result in just a few hours.
Distribution of bowls and disinfectant soap to LF patients to wash and clean their limbs, to prevent infections.
Nighttime blood draw, Busua village, Ghana. Doctors examine the blood through a microscope to look for moving LF worms, which are most actively transmitted at night.
Lab technologists extracting DNA from filarial worms, at KCCR (Kumasi Centre for Collaborative Research in Tropical Medicine), Kwame Nkrumah University of Science and Technology (KNUST), Kumasi, Ghana.
Dr. Alexander Debrah, co-lead researcher of the Filariasis Project at KCCR (Kumasi, Ghana), examines a filarial worm sample in a microscope at the university’s parasitology lab.

All photos, credit ©: DNDi/Cosmos/Sylvain Cherkaoui

Policy advocacy River blindness

Read, watch, share

Loading...
Statements
9 Jun 2026

DNDi Statement at the UN Multi-Stakeholder Hearing on Pandemic Prevention, Preparedness, and Response (PPPR)

Press releases
8 Jun 2026

DNDi, GARDP, and MMV join forces to accelerate drug development for patients in greatest need

Statements
19 May 2026

DNDi interventions at the 79th World Health Assembly

Dr Sergio Sosa-Estani
Statements
15 May 2026

DNDi statement on hantavirus outbreak: ‘Investment in pandemic preparedness efforts remains insufficient.’

Statements
13 May 2026

DNDi’s briefing note for 79th World Health Assembly

Close up of legs with sandals on a dry soil
Press releases
12 May 2026

DNDi welcomes GHIT support for global evaluation and registration of fosravuconazole for eumycetoma, in collaboration with Eisai

Press releases
27 Apr 2026

Thailand registers ravidasvir, a simple-to-use and effective antiviral for hepatitis C, expanding treatment options for Thai patients

Stories

Lab lessons that matter: Pharmacy students help bridge the gap in research for neglected diseases

VIEW ALL

Help neglected patients

To date, we have delivered fourteen new treatments, saving millions of lives.

Our goal is to deliver 25 new treatments in our first 25 years. You can help us get there. 

GIVE NOW
Linkedin-in Instagram Youtube X-twitter Tiktok Facebook-f
International non-profit developing safe, effective, and affordable treatments for the most neglected patients.

Learn more

  • Diseases
  • Neglected tropical diseases
  • R&D portfolio
  • Policy advocacy

Get in touch

  • Our offices
  • Contact us
  • Integrity Line

Support us

  • Donate
  • Subscribe to eNews

Work with us

  • Join research networks
  • Jobs
  • RFPs
  • Terms of Use   
  •   Acceptable Use Policy   
  •   Privacy Policy   
  •   Cookie Policy   
  •   Our policies   

  • Except for images, films, and trademarks which are subject to DNDi’s Terms of Use, content on this site is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International license